
Migraine therapies multiply: CGRP drugs, Botox, and neuromodulation
Researchers are widening the migraine toolbox with CGRP-targeting drugs that reduce attack frequency for many, Botox injections that can lower migraine frequency by blocking CGRP release, and neuromodulation devices that alter neural pain pathways—though responses vary, long-term relief isn’t universal and access to these therapies can be uneven.











